Neuphoria Therapeutics Statistics Share Statistics Neuphoria Therapeutics has 1.88M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 1.88M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 391 FTD / Avg. Volume 1.18%
Short Selling Information The latest short interest is 12.39K, so 0.66% of the outstanding
shares have been sold short.
Short Interest 12.39K Short % of Shares Out 0.66% Short % of Float 0.66% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -80.06 and the forward
PE ratio is -1.1.
Neuphoria Therapeutics's PEG ratio is
1.94.
PE Ratio -80.06 Forward PE -1.1 PS Ratio 0 Forward PS n/a PB Ratio 70.92 P/FCF Ratio -84.49 PEG Ratio 1.94
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Neuphoria Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.45,
with a Debt / Equity ratio of 0.02.
Current Ratio 3.45 Quick Ratio 3.45 Debt / Equity 0.02 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.94M Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -87.32K Effective Tax Rate 0.56%
Stock Price Statistics The stock price has increased by -2.44% in the
last 52 weeks. The beta is 0.53, so Neuphoria Therapeutics's
price volatility has been higher than the market average.
Beta 0.53 52-Week Price Change -2.44% 50-Day Moving Average 7.33 200-Day Moving Average 5.17 Relative Strength Index (RSI) 44.66 Average Volume (20 Days) 33,012
Income Statement
Revenue n/a Gross Profit n/a Operating Income -17.89M Net Income -15.49M EBITDA -17.13M EBIT -17.8M Earnings Per Share (EPS) -0.1
Full Income Statement Balance Sheet The company has 12.61M in cash and 272.74K in
debt, giving a net cash position of 12.34M.
Cash & Cash Equivalents 12.61M Total Debt 272.74K Net Cash 12.34M Retained Earnings -177.98M Total Assets 30.71M Working Capital 15.54M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.68M
and capital expenditures 0, giving a free cash flow of -14.68M.
Operating Cash Flow -14.68M Capital Expenditures n/a Free Cash Flow -14.68M FCF Per Share -0.1
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NEUP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for NEUP is $21,
which is 191.7% higher than the current price. The consensus rating is "Strong Buy".
Price Target $21 Price Target Difference 191.7% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 24, 2024. It was a
backward
split with a ratio of 1:12.
Last Split Date Dec 24, 2024 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -4.39 Piotroski F-Score 5
